Cleveland Clinic Cancer Advances
The Potential of CAR T-Cell Therapy for Chronic Lymphocytic Leukemia (CLL)
20 Feb 2025
Description
Vice Chair of the Center for Immunotherapy & Precision Immuno-Oncology, J. Joseph Melenhorst, PhD, joins the Cancer Advances Podcast to discuss the potential of CAR T-cell therapy for chronic lymphocytic leukemia (CLL). Listen as Dr. Melenhorst explains how advancements in cell therapy are overcoming challenges like T cell exhaustion, improving response rates, and how novel approaches could improve treatment outcomes.
Audio
Featured in this Episode
No persons identified in this episode.
Transcription
No transcription available yet
Help us prioritize this episode for transcription by upvoting it.
0
upvotes
Popular episodes get transcribed faster